KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 106 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $743,471 | +89.2% | 492,365 | +8.4% | 0.00% | – |
Q4 2023 | $392,971 | -35.2% | 454,302 | +0.4% | 0.00% | – |
Q3 2023 | $606,224 | -26.9% | 452,406 | -2.4% | 0.00% | – |
Q2 2023 | $829,726 | +11893.7% | 463,534 | -73.9% | 0.00% | -100.0% |
Q1 2023 | $6,918 | +27.7% | 1,778,532 | +11.6% | 0.00% | +50.0% |
Q4 2022 | $5,419 | -99.9% | 1,593,710 | -19.1% | 0.00% | -50.0% |
Q3 2022 | $10,762,000 | +25.9% | 1,971,048 | +4.0% | 0.00% | +33.3% |
Q2 2022 | $8,548,000 | -28.3% | 1,895,378 | +4.2% | 0.00% | -25.0% |
Q1 2022 | $11,915,000 | +77.4% | 1,819,048 | +53.6% | 0.00% | +100.0% |
Q4 2021 | $6,715,000 | -1.1% | 1,184,310 | +5.8% | 0.00% | 0.0% |
Q3 2021 | $6,792,000 | -42.1% | 1,119,008 | -1.5% | 0.00% | -33.3% |
Q2 2021 | $11,723,000 | +19.9% | 1,135,916 | +22.2% | 0.00% | 0.0% |
Q1 2021 | $9,779,000 | -38.5% | 929,561 | -9.5% | 0.00% | -40.0% |
Q4 2020 | $15,907,000 | +3.5% | 1,027,588 | -2.3% | 0.01% | -16.7% |
Q3 2020 | $15,363,000 | +91.9% | 1,052,236 | +148.9% | 0.01% | +100.0% |
Q2 2020 | $8,006,000 | +46.6% | 422,746 | +48.7% | 0.00% | 0.0% |
Q1 2020 | $5,460,000 | -38.4% | 284,219 | -38.5% | 0.00% | 0.0% |
Q4 2019 | $8,863,000 | +131.2% | 462,347 | +16.0% | 0.00% | +50.0% |
Q3 2019 | $3,834,000 | +66.0% | 398,523 | +3.3% | 0.00% | +100.0% |
Q2 2019 | $2,310,000 | +356.5% | 385,707 | +3448.4% | 0.00% | -66.7% |
Q2 2014 | $506,000 | +57.1% | 10,870 | +4.2% | 0.00% | +50.0% |
Q1 2014 | $322,000 | -24.2% | 10,430 | -43.8% | 0.00% | -33.3% |
Q4 2013 | $425,000 | – | 18,551 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |